Novel Inhibitors of Ornithine Decarboxylase ofLeishmaniaParasite (LdODC): The Parasite ResistsLdODC Inhibition by Overexpression of Spermidine Synthase-Reference-Cited by-同舟云学术

Novel Inhibitors of Ornithine Decarboxylase ofLeishmaniaParasite (LdODC): The Parasite ResistsLdODC Inhibition by Overexpression of Spermidine Synthase

Published:2015-10-13 Issue:3 Volume:87 Page:352-360
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Das Mousumi¹,Singh Shalini¹,Dubey Vikash Kumar¹

Affiliation:

1. Department of Biosciences and Bioengineering; Indian Institute of Technology Guwahati; Assam 781039 India

Funder

Indian Council of Medical Research

Government of India

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cbdd.12665/fullpdf

Reference23 articles.

1. Drug regimens for visceral leishmaniasis in Mediterranean countries;Gradoni;Tropical Med Int Health,2008

2. Rational approaches for drug designing against leishmaniasis;Shukla;Appl Biochem Biotechnol,2010

3. Putrescine biosynthesis in mammalian tissues;Coleman;Biochem J,2004

4. Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism;Krauth-Siegel;Biochim Biophys Acta,2008

5. Molecular mechanism underlying antileishmanial effect of oxabicyclo[3.3.1]nonanones: inhibition of key redox enzymes of the pathogen;Saudagar;Eur J Pharm Biopharm,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on potential therapeutic targets for the treatment of leishmaniasis;Parasitology International;2024-06

2. Compounds with potentialities as novel chemotherapeutic agents in leishmaniasis at preclinical level;Experimental Parasitology;2024-05

3. Polyamine Metabolism for Drug Intervention in Trypanosomatids;Pathogens;2024-01-16

4. Molecular-level strategic goals and repressors in Leishmaniasis – Integrated data to accelerate target-based heterocyclic scaffolds;European Journal of Medicinal Chemistry;2023-09

5. Drug repositioning to discover novel ornithine decarboxylase inhibitors against visceral leishmaniasis;Journal of Molecular Recognition;2023-05-15